[Regurgitation esophagitis treated with Gaviscon].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000464:Alginates / Q000627:therapeutic use*; D000535:Aluminum / Q000627:therapeutic use; D000863:Antacids / Q000627:therapeutic use*; D001639:Bicarbonates / Q000627:therapeutic use*; D002648:Child; D004942:Esophagitis, Peptic / Q000188:drug therapy*; D004945:Esophagoscopy; D005260:Female; D005745:Gastric Acidity Determination; D005782:Gels; D006548:Hernia, Diaphragmatic / Q000150:complications; D006801:Humans; D006878:Hydroxides / Q000627:therapeutic use; D008274:Magnesium / Q000627:therapeutic use; D008297:Male; D008722:Methods; D008875:Middle Aged; D012822:Silicon Dioxide / Q000627:therapeutic use; D012964:Sodium / Q000627:therapeutic use; D013997:Time Factors
D000464:Alginates; D000863:Antacids; D001639:Bicarbonates; D005782:Gels; D006878:Hydroxides; D012822:Silicon Dioxide; D012964:Sodium; D000535:Aluminum; D008274:Magnesium
Regurgitationsoesophagitis behandlet med Gaviscon.